Introduction: Introducing Innovation into Practice: Technical and Ethical Analyses of PGD and ICSI Technologies

Journal of Law, Medicine and Ethics

Volumn 26, Issue 1, 1998, Pages 5-6

  White, Gladys B ^a   McClure, Michael E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EMBRYO; FRANCE; GENETICS AND REPRODUCTION; HUMAN; INFERTILITY; INFERTILITY THERAPY; INTERNATIONAL COOPERATION; INTRACYTOPLASMIC SPERM INJECTION; JURISPRUDENCE; MALE; NEW YORK STATE TASK FORCE ON LIFE AND THE LAW; PRENATAL DIAGNOSIS; PRENATAL EXPOSURE; RISK; RISK ASSESSMENT; UNITED KINGDOM; UNITED STATES;

GENETICS AND REPRODUCTION; NEW YORK STATE TASK FORCE ON LIFE AND THE LAW;

EMBRYO; FRANCE; GREAT BRITAIN; HUMANS; INFERTILITY; INTERNATIONAL COOPERATION; INTERNATIONALITY; JURISPRUDENCE; MEN; PREIMPLANTATION DIAGNOSIS; PRENATAL EXPOSURE DELAYED EFFECTS; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK; RISK ASSESSMENT; SPERM INJECTIONS, INTRACYTOPLASMIC; UNITED STATES;

EID: 0032008782     PISSN: 10731105     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-720X.1998.tb01900.x     Document Type: Article

References (13)

1. See generally U.S. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology, and RESOLVE, 1995 Assisted Reproductive Technology Success Rates, National Summary and Fertility Clinic Reports (Washington, D.C.: U.S. Department of Health and Human Services, Vois. 1-3, Dec. 1997) [henceforth Assisted Reproductive Technology].
2. See generally R.J. Tasca and M.E. McClure, "The Emerging Technology and Application of Preimplantation Genetic Diagnosis," Journal of Law, Medicine & Ethics, 26 (1998): 7-16.
3. See Assisted Reproductive Technology, supra note 1, at 11.
4. See J. Cummins, Reproduction, "ICSI May Foster Birth Defects," Journal of NIH Research, 9, no. 2 (1997): 34, 36, 38, 40; and H. Tournaye and A. Van Steirteghem, Reproduction, "ICSI Concerns Do Not Outweigh Its Benefits," Journal of NIH Research, 9, no. 2 (1997): 35, 37, 39, 40. Compare to A. Van Steirteghem et al., "Ethical Considerations of Intracytoplasmic Sperm Injection," in F. Shenfield and C. Sureau, eds., Ethical Dilemmas in Assisted Reproduction (London: Parthenon Press, Studies in Profertility Series, Vol. 7, 1997): 51-56.
5. See J. Cummins, Reproduction, "ICSI May Foster Birth Defects," Journal of NIH Research, 9, no. 2 (1997): 34, 36, 38, 40; and H. Tournaye and A. Van Steirteghem, Reproduction, "ICSI Concerns Do Not Outweigh Its Benefits," Journal of NIH Research, 9, no. 2 (1997): 35, 37, 39, 40. Compare to A. Van Steirteghem et al., "Ethical Considerations of Intracytoplasmic Sperm Injection," in F. Shenfield and C. Sureau, eds., Ethical Dilemmas in Assisted Reproduction (London: Parthenon Press, Studies in Profertility Series, Vol. 7, 1997): 51-56.
6. See J. Cummins, Reproduction, "ICSI May Foster Birth Defects," Journal of NIH Research, 9, no. 2 (1997): 34, 36, 38, 40; and H. Tournaye and A. Van Steirteghem, Reproduction, "ICSI Concerns Do Not Outweigh Its Benefits," Journal of NIH Research, 9, no. 2 (1997): 35, 37, 39, 40. Compare to A. Van Steirteghem et al., "Ethical Considerations of Intracytoplasmic Sperm Injection," in F. Shenfield and C. Sureau, eds., Ethical Dilemmas in Assisted Reproduction (London: Parthenon Press, Studies in Profertility Series, Vol. 7, 1997): 51-56.
7. See M. Bonduelle et al., "Mental Development of 201 ICSI Children at 2 Years of Age," Lancet, 351 (1998): 1553; and J.R. Bowen et al., "Medical and Developmental Outcome at 1 Year from Children Conceived by Intracytoplasmic Sperm Injection," Lancet, 351 (1998): 1529-34.
8. See M. Bonduelle et al., "Mental Development of 201 ICSI Children at 2 Years of Age," Lancet, 351 (1998): 1553; and J.R. Bowen et al., "Medical and Developmental Outcome at 1 Year from Children Conceived by Intracytoplasmic Sperm Injection," Lancet, 351 (1998): 1529-34.
9. See J. Milliez and C. Sureau, "Pre-Implantation Diagnosis and the Eugenics Debate: Our Responsibility to Future Generations," in Shenfield and Sureau, supra note 4, at 57-66.
10. New York State Task Force on Life and the Law, Assisted Reproductive Technologies: Analysis and Recommendations for Public Policy (New York: New York State Task Force on Life and the Law, Apr. 1998): at xiv.
11. See Van Steirteghem et al., supra note 4.
12. See generally G. Schatten et al., "Cell and Molecular Biological Challenges of ICSI: ART Before Science?," Journal of Law, Medicine & Ethics, 26 (1998): 29-37.
13. See generally J.R. Botkin, "Ethical Issues and Practical Problems in Preimplantation Genetic Diagnosis," Journal of Law, Medicine & Ethics, 26 (1998): 17-28.